Taliglucerase alfa

Generic name: Taliglucerase Alfa
Brand names: Elelyso
Dosage form: intravenous powder for injection (200 units)
Drug class: Lysosomal enzymes

Usage of Taliglucerase alfa

Taliglucerase is used as an enzyme replacement in people with Type I Gaucher disease in adults and children at least 4 years old.

Gaucher disease is a genetic condition in which the body lacks the enzyme needed to break down certain fatty materials (lipids). Lipids can build up in the body, causing symptoms such as easy bruising or bleeding, weakness, anemia, bone or joint pain, enlarged liver or spleen, or weakened bones that are easily fractured.

Taliglucerase may improve the condition of the liver, spleen, bones, and blood cells in people with Type I Gaucher disease. However, taliglucerase is not a cure for this condition.

Taliglucerase may also be used for purposes not listed in this medication guide.

Taliglucerase alfa side effects

Get emergency medical help if you have signs of an allergic Reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Some people receiving a taliglucerase alfa injection have had a reaction when the medicine was injected, or up to 3 hours later. Tell your caregivers right away if you have:

dizziness or feeling like you might pass out;

chest tightness, wheezing;

swelling in your face;

cough, throat irritation;

flushing (warmth, redness, or tingly feeling);

nausea, vomiting;

skin rash, itching, or redness.

Common side effects of taliglucerase alfa may include:

headache;

rash, itching, warmth or tingly feeling;

dizziness or tired feeling;

nausea, stomach pain, vomiting; or

joint pain, back pain, pain in your arms or legs.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Taliglucerase alfa

Tell your doctor if you are pregnant. It is not known whether taliglucerase alfa will harm an unborn baby. However, having untreated or uncontrolled Type I Gaucher disease during pregnancy may cause new or worsening symptoms in the mother, or complications in the baby such as growth problems or bleeding. The benefit of treating your disease may outweigh any risks to the baby.

It may not be safe to breastfeed while using this medicine. Ask your doctor about any risk.

Relate drugs

How to use Taliglucerase alfa

Usual Adult Dose for Gaucher Disease:

Treatment-naive: -Initial dose: 60 units/kg IV every other weekConversion from Imiglucerase: -For patients on a stable dose of imiglucerase: Begin at SAMe units/kg dose IV every other week Dose adjustments should be based on individual's therapeutic goals Comments: -Administer as an IV infusion over 60 to 120 minutes every other week; in adult patients, an initial infusion rate of 1.2 mL/minute should be used.-After tolerability to infusion is established, the infusion rate may be increased, but should not exceed the maximum recommended infusion rate of 2.2 mL/minute; infusion should be delivered over a minimum or 60 minutes. Use: For long-term enzyme replacement therapy (ERT) for patients with cOnfirmed diagnosis of type 1 Gaucher disease

Usual Pediatric Dose for Gaucher Disease:

4 years or older:Treatment-naive: Initial dose: 60 units/kg IV every other weekConversion from imiglucerase: -For patients on a stable dose of imiglucerase: Begin with same units/kg dose IV every other week Dose adjustments should be based on individual's therapeutic goals Comments: -Administer as an IV infusion over 60 to 120 minutes every other week; in adult patients, an initial infusion rate of 1.2 mL/minute should be used.-After tolerability to infusion is established, the infusion rate may be increased, but should not exceed the maximum recommended infusion rate of 2.2 mL/minute; infusion should be delivered over a minimum or 60 minutes. Use: For the treatment of patients with a confirmed diagnosis of Type 1 Gaucher disease.

Warnings

Some people receiving a taliglucerase alfa injection have had a reaction when the medicine was injected, or up to 3 hours later. Tell your caregivers right away if you have a sudden headache, dizziness, warmth or tingling, chest pain, wheezing, nausea, or a red skin rash.

What other drugs will affect Taliglucerase alfa

Other drugs may affect taliglucerase alfa, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.